BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37741968)

  • 21. Closed-loop trans-skull ultrasound hyperthermia leads to improved drug delivery from thermosensitive drugs and promotes changes in vascular transport dynamics in brain tumors.
    Kim C; Guo Y; Velalopoulou A; Leisen J; Motamarry A; Ramajayam K; Aryal M; Haemmerich D; Arvanitis CD
    Theranostics; 2021; 11(15):7276-7293. PubMed ID: 34158850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor suppression effect of ultrasound-sensitive nanoparticles with focused ultrasound in a pancreas cancer xenograft model.
    Kim S; Lee JY; Park EJ; Ahn YD; Cheon Y; Sim W; Lee HJ
    Eur Radiol Exp; 2024 Mar; 8(1):39. PubMed ID: 38503996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Triggered radiosensitizer delivery using thermosensitive liposomes and hyperthermia improves efficacy of radiotherapy: An in vitro proof of concept study.
    Besse HC; Bos C; Zandvliet MMJM; van der Wurff-Jacobs K; Moonen CTW; Deckers R
    PLoS One; 2018; 13(9):e0204063. PubMed ID: 30226898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased Duration of Heating Boosts Local Drug Deposition during Radiofrequency Ablation in Combination with Thermally Sensitive Liposomes (ThermoDox) in a Porcine Model.
    Swenson CE; Haemmerich D; Maul DH; Knox B; Ehrhart N; Reed RA
    PLoS One; 2015; 10(10):e0139752. PubMed ID: 26431204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of active hexose correlated compound on survival of patients with resectable/borderline resectable pancreatic cancer: a study protocol for a double-blind randomized phase II study.
    Hashimoto D; Satoi S; Ishikawa H; Kodera Y; Kamei K; Hirano S; Fujii T; Uemura K; Tsuchida A; Yamada S; Yamamoto T; Hirota K; Sekimoto M
    Trials; 2022 Feb; 23(1):135. PubMed ID: 35151367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-circulating magnetoliposomes as surrogates for assessing pancreatic tumour permeability and nanoparticle deposition.
    Moloney C; Roy Chaudhuri T; Spernyak JA; Straubinger RM; Brougham DF
    Acta Biomater; 2023 Mar; 158():611-624. PubMed ID: 36603732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heat-activated drug delivery increases tumor accumulation of synergistic chemotherapies.
    Dunne M; Epp-Ducharme B; Sofias AM; Regenold M; Dubins DN; Allen C
    J Control Release; 2019 Aug; 308():197-208. PubMed ID: 31195059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperthermia-enhanced targeted drug delivery using magnetic resonance-guided focussed ultrasound: a pre-clinical study in a genetic model of pancreatic cancer.
    Farr N; Wang YN; D'Andrea S; Starr F; Partanen A; Gravelle KM; McCune JS; Risler LJ; Whang SG; Chang A; Hingorani SR; Lee D; Hwang JH
    Int J Hyperthermia; 2018 May; 34(3):284-291. PubMed ID: 28715967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MAPLE-PD trial (Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer during Pancreaticoduodenectomy): study protocol for a multicenter randomized controlled trial of 354 patients with pancreatic ductal adenocarcinoma.
    Hirono S; Kawai M; Okada KI; Fujii T; Sho M; Satoi S; Amano R; Eguchi H; Mataki Y; Nakamura M; Matsumoto I; Baba H; Tani M; Kawabata Y; Nagakawa Y; Yamada S; Murakami Y; Shimokawa T; Yamaue H
    Trials; 2018 Nov; 19(1):613. PubMed ID: 30409152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. To heat or not to heat: Challenges with clinical translation of thermosensitive liposomes.
    Dou Y; Hynynen K; Allen C
    J Control Release; 2017 Mar; 249():63-73. PubMed ID: 28122204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study protocol for an open-label, single-arm, phase Ib/II study of combination of toripalimab, nab-paclitaxel, and gemcitabine as the first-line treatment for patients with unresectable pancreatic ductal adenocarcinoma.
    Shui L; Cheng K; Li X; Shui P; Zhou X; Li J; Yi C; Cao D
    BMC Cancer; 2020 Jul; 20(1):636. PubMed ID: 32646394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thermosensitive liposomal doxorubicin plus radiofrequency ablation increased tumor destruction and improved survival in patients with medium and large hepatocellular carcinoma: A randomized, double-blinded, dummy-controlled clinical trial in a single center.
    Yang W; Lee JC; Chen MH; Zhang ZY; Bai XM; Yin SS; Cao K; Wang S; Wu W; Yan K
    J Cancer Res Ther; 2019; 15(4):773-783. PubMed ID: 31436231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic efficacy of targeting chemotherapy using local hyperthermia and thermosensitive liposome: evaluation of drug distribution in a rat glioma model.
    Aoki H; Kakinuma K; Morita K; Kato M; Uzuka T; Igor G; Takahashi H; Tanaka R
    Int J Hyperthermia; 2004 Sep; 20(6):595-605. PubMed ID: 15370816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Turning down the heat: The case for mild hyperthermia and thermosensitive liposomes.
    Regenold M; Bannigan P; Evans JC; Waspe A; Temple MJ; Allen C
    Nanomedicine; 2022 Feb; 40():102484. PubMed ID: 34748961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperthermia-induced doxorubicin delivery from thermosensitive liposomes via MR-HIFU in a pig model.
    Sebeke LC; Castillo Gómez JD; Heijman E; Rademann P; Simon AC; Ekdawi S; Vlachakis S; Toker D; Mink BL; Schubert-Quecke C; Yeo SY; Schmidt P; Lucas C; Brodesser S; Hossann M; Lindner LH; Grüll H
    J Control Release; 2022 Mar; 343():798-812. PubMed ID: 35134460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Method of hyperthermia and tumor size influence effectiveness of doxorubicin release from thermosensitive liposomes in experimental tumors.
    Willerding L; Limmer S; Hossann M; Zengerle A; Wachholz K; Ten Hagen TL; Koning GA; Sroka R; Lindner LH; Peller M
    J Control Release; 2016 Jan; 222():47-55. PubMed ID: 26658073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted drug delivery by high intensity focused ultrasound mediated hyperthermia combined with temperature-sensitive liposomes: computational modelling and preliminary in vivovalidation.
    Gasselhuber A; Dreher MR; Partanen A; Yarmolenko PS; Woods D; Wood BJ; Haemmerich D
    Int J Hyperthermia; 2012; 28(4):337-48. PubMed ID: 22621735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of injected dose on localized tumor accumulation and cardiac uptake of doxorubicin in a Vx2 rabbit tumor model using MR-HIFU mild hyperthermia and thermosensitive liposomes.
    Cheng B; Bing C; Staruch RM; Shaikh S; Wodzak Staruch M; Szczepanski D; Williams NS; Laetsch TW; Chopra R
    Int J Hyperthermia; 2020; 37(1):1052-1059. PubMed ID: 32892667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short-time focused ultrasound hyperthermia enhances liposomal doxorubicin delivery and antitumor efficacy for brain metastasis of breast cancer.
    Wu SK; Chiang CF; Hsu YH; Lin TH; Liou HC; Fu WM; Lin WL
    Int J Nanomedicine; 2014; 9():4485-94. PubMed ID: 25278753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.